Should I Buy UiPath Stock in 2025? Expert NZ Analysis
Is UiPath stock a buy right now?
UiPath Inc. (NYSE: PATH) stands out as a leader in the fast-evolving automation software sector, making it a compelling consideration for New Zealand investors seeking innovative technology exposure. As of 30 May 2025, UiPath shares are trading at approximately $12.94 USD, with a robust average daily volume of 13.4 million shares—highlighting continued market interest. Recent months have seen the company report steady annual recurring revenue growth (+12% YoY to $1.693 billion) and launch the next-generation UiPath Platform, expanding its reach into agentic automation and AI orchestration. While some volatility has accompanied changes in the leadership team and regulatory noise, market sentiment remains constructive, buoyed by strong technical signals (RSI 60.58 and MACD positive) and the company's proven ability to innovate and retain enterprise clients. With a forward P/E of 23.53, the valuation reflects expected sector growth rather than excessive optimism, especially given UiPath’s consistent cash generation and industry accolades. As automation and AI gain traction across global business, particularly in sectors central to the NZ economy such as banking and logistics, UiPath’s position is well aligned for future expansion. Consensus from more than 29 national and international banks sets a target price of $16.80, suggesting meaningful upside for patient investors.
- ✅Consistent double-digit ARR growth demonstrates sustained business momentum.
- ✅Strong cash position ($1.59 billion) allows for ongoing R&D and strategic expansion.
- ✅Industry leader in automation, recognized repeatedly by IDC and Everest Group.
- ✅Successful product launches in agentic automation enhance market relevance.
- ✅Strategic integrations with Microsoft broaden enterprise adoption and partnership opportunities.
- ❌Premium forward P/E signals heightened expectations; future growth must justify valuation.
- ❌Competitive landscape remains intense, with pressure from other established enterprise automation firms.
- ✅Consistent double-digit ARR growth demonstrates sustained business momentum.
- ✅Strong cash position ($1.59 billion) allows for ongoing R&D and strategic expansion.
- ✅Industry leader in automation, recognized repeatedly by IDC and Everest Group.
- ✅Successful product launches in agentic automation enhance market relevance.
- ✅Strategic integrations with Microsoft broaden enterprise adoption and partnership opportunities.
Is UiPath stock a buy right now?
- ✅Consistent double-digit ARR growth demonstrates sustained business momentum.
- ✅Strong cash position ($1.59 billion) allows for ongoing R&D and strategic expansion.
- ✅Industry leader in automation, recognized repeatedly by IDC and Everest Group.
- ✅Successful product launches in agentic automation enhance market relevance.
- ✅Strategic integrations with Microsoft broaden enterprise adoption and partnership opportunities.
- ❌Premium forward P/E signals heightened expectations; future growth must justify valuation.
- ❌Competitive landscape remains intense, with pressure from other established enterprise automation firms.
- ✅Consistent double-digit ARR growth demonstrates sustained business momentum.
- ✅Strong cash position ($1.59 billion) allows for ongoing R&D and strategic expansion.
- ✅Industry leader in automation, recognized repeatedly by IDC and Everest Group.
- ✅Successful product launches in agentic automation enhance market relevance.
- ✅Strategic integrations with Microsoft broaden enterprise adoption and partnership opportunities.
- What is UiPath?
- What is the price of UiPath stock?
- Our full analysis of the UiPath stock
- How to buy UiPath stock in New Zealand?
- Our 7 tips for buying UiPath stock
- The latest news about UiPath
- FAQ
What is UiPath?
Indicator | Value | Analysis |
---|---|---|
🏳️ Nationality | United States | US-based company supports strong access to global capital and tech talent. |
💼 Market | NYSE (New York Stock Exchange) | Listed on a major US exchange ensures high liquidity for NZ investors. |
🏛️ ISIN code | US90364P1057 | Unique global security identifier for UiPath stock transactions. |
👤 CEO | Daniel Dines | Founder Daniel Dines' return as CEO may strengthen product vision. |
🏢 Market cap | $6.92 billion USD | Mid-cap size reflects industry relevance but some growth stage risk. |
📈 Revenue | $1.549–$1.554 billion USD (FY2026E) | Modest revenue growth; automation sector provides long-term opportunity. |
💹 EBITDA | ~$305 million USD (FY2026E, Non-GAAP Op. Inc.) | Positive EBITDA signals improving profitability, but still not large. |
📊 P/E Ratio (Price/Earnings) | 23.53 (Forward) | Premium valuation suggests high investor expectations for future growth. |
What is the price of UiPath stock?
The price of UiPath stock is rising this week. At $12.94 USD per share, UiPath has seen a positive after-hours boost to $14.37, up 11.05% in the last 24 hours and delivering a 5.55% gain over the past week. The company’s market capitalisation now stands at $6.92 billion USD, with an average daily trading volume of 13.4 million shares over the last three months. UiPath currently trades at a forward P/E ratio of 23.53, with a dividend yield of 0.00% and a beta of 1.01, reflecting movement in line with the broader market. With strong volume and technical buy signals, PATH offers NZ investors a dynamic option in the automation software sector, though market fluctuations are worth monitoring closely.
Check out New Zealand's best brokers!Compare brokersOur full analysis of the UiPath stock
We have thoroughly reviewed UiPath's latest financial results and the stock’s trajectory over the past three years, distilling insights from our proprietary algorithms that synthesise financial metrics, technical signals, peer comparison, and broad market data. UiPath, a leader in the fast-evolving automation software landscape, not only shows resilience but also possesses attributes that investors searching for exposure to enterprise AI and automation may find highly compelling. So, why might UiPath stock once again become a strategic entry point into the AI-powered automation sector in 2025?
Recent Performance and Market Context
UiPath’s stock has returned to investor focus after a period of recalibration, outperforming many in the software sector with a robust year-to-date performance. As of May 30, 2025, PATH trades at $12.94 USD, and after its latest earnings release saw a notable after-hours surge to $14.37 (+11.05%), highlighting strong market confidence in its outlook.
Over the last 12 months, the stock has advanced by 5.55%, outperforming a number of high-beta technology peers during a volatile period for the NASDAQ and global software markets. The trading range over the past year ($9.38–$15.93) confirms strong investor engagement, with a substantial daily volume averaging 13.4 million shares—a sign of robust interest and liquidity.
This period has seen UiPath benefit from key macro and sectoral tailwinds: enterprise digital transformation continues at pace, with RPA and agentic AI at the centre of corporate technology budgets. Global organisations—particularly in markets with talent shortages such as New Zealand and Australia—are increasingly prioritising automation as a core strategic lever. Against this backdrop, UiPath stands out for its product innovation and established enterprise relationships.
Technical Analysis
From a technical perspective, UiPath’s current setup is decisively bullish. The 14-day Relative Strength Index (RSI) sits at 60.58, conveying solid momentum but with room for further upside before entering overbought territory. The Moving Average Convergence Divergence (MACD) indicator prints a positive 0.11, confirming that an ascending trend remains intact.
Moving Average | Value |
---|---|
20-Day MA | $12.81 |
50-Day MA | $12.55 |
200-Day MA | $12.11 |
PATH is currently consolidating above the $12.67–$12.73 support band—a region repeatedly defended by buyers in recent months. Immediate resistance lies at $13.03–$13.12; a breakout and sustained close above this range would signal the start of a medium-term rally and likely trigger rapid momentum buying.
- Strong support repeatedly attracting institutional flows
- A “higher lows” pattern pointing towards an emerging uptrend
- Bullish reversal signals coinciding with the recent upbeat earnings
This landscape may offer an ideal tactical window for new or additional positioning, with momentum and risk/reward skewed positively.
Fundamental Analysis
UiPath’s fundamentals underpin its technical appeal. In Q1 FY2026, the company delivered $357 million in revenue (+6% YoY), with Annual Recurring Revenue (ARR) climbing to $1.693 billion (+12% YoY), and net new ARR of $27 million—clear evidence of enterprise expansion and high-quality deal flow. Notably, both GAAP (82%) and non-GAAP (84%) gross margins remain world-class, illustrating the scalability of UiPath’s software delivery model.
UiPath’s cash generation continues to impress: $119 million in operating cash flow and $117 million in non-GAAP adjusted free cash flow in the last quarter alone. This financial agility is paired with a war chest of $1.59 billion, and manageable debt of $77.8 million, yielding a formidable current ratio of 2.93—imparting resilience and the ability to invest opportunistically through cycles.
Valuation remains attractive on a growth-adjusted basis. While the forward P/E ratio of 23.53 attaches a premium, market participants are rewarding UiPath for durable growth and its leadership in a sector expected to compound at double-digit rates globally. The Price/Sales ratio (5.07) and Price/Book (3.75) both compare favourably with other high-growth SaaS and automation peers.
- Leading position in global automation and RPA
- Strong brand and recurring enterprise revenue base
- Proven innovation pipeline, particularly in agentic AI and orchestration
UiPath’s competitive moat grows as it integrates advanced AI and expands its platform, differentiating itself from pure-play RPA vendors and encroaching on broader enterprise software budgets.
Volume and Liquidity
Consistently high trading volume (average 13.4 million shares daily) speaks to deep market liquidity and enduring institutional engagement. Nearly 74% of shares are institutionally held, signposting significant professional investor conviction. The relatively moderate float and short interest (8.44%) create the conditions for dynamic price discovery—should positive catalysts materialise, the path for an outsized re-rating remains open.
From a New Zealand investor’s perspective, this level of liquidity means tactical positions can be built or exited efficiently, an overlooked but crucial advantage in the sometimes volatile US technology sector.
Catalysts and Positive Outlook
- Product Innovation: Launch of the next-generation UiPath Platform™ for agentic automation, UiPath Maestro (orchestration for AI agents), and the new Test Cloud solution position the company at the leading edge of enterprise AI adoption.
- Strategic Partnerships: Deep integrations with Microsoft Copilot Studio offer path-breaking opportunities for account expansion and stickier enterprise deployment.
- Sustained Market Recognition: Repeated recognition by IDC and Everest Group as an automation and document processing leader cements the brand’s global standing.
- Financial Guidance: Management projects FY2026 revenue reaching $1.549–$1.554 billion, with ARR expected to top $1.82 billion and growing non-GAAP operating income. This guidance signals both operational leverage and shareholder value creation potential.
- Emerging ESG and Regulatory Drivers: As businesses seek to drive productivity and compliance, agentic automation aligns with the shifting regulatory and sustainability agenda, deepening addressable market appeal.
Combined, these vectors create a virtuous cycle of product leadership reinforcing financial momentum and vice versa.
Investment Strategies
UiPath presents a multi-horizon opportunity for investors seeking exposure to automation, AI, and future-proofed technology platforms. Arguments can be constructed for entry across timeframes:
- Short-Term:
- Recent break above the $12.81 and $12.94 resistance zones, with after-hours action above $14, suggests potential for a technically driven acceleration.
- Tactical traders may identify an attractive entry at support ($12.67–$13.12), with upside towards the $15.93 yearly high.
- Medium-Term:
- Positive earnings surprises, major product rollouts, and increasing ARR all underpin likely upward revisions to consensus fair value.
- The risk/reward profile is especially compelling ahead of imminent catalysts, such as new product adoption metrics or additional large-scale partnerships.
- Long-Term:
- The secular trend toward AI-driven automation is robust, and UiPath’s market share gains, recurring revenue model, balance sheet strength, and strategic leadership provide long-duration compounding credentials.
- Investors seeking to align portfolios with the global automation supercycle may find the current consolidation range a notable entry point for phased accumulation.
Positioning ahead of the next leg of sector growth, particularly as institutional flows increase and competitive benchmarks recalibrate, appears strategically rational for long-range portfolios.
Is it the Right Time to Buy UiPath?
Summing up, UiPath combines exceptional operational performance, compelling technical structure, strong balance sheet dynamics, and leadership in a sector at the heart of digital transformation. The fundamentals justify renewed investor focus: revenue and ARR are growing robustly, margins and cash flows are best-in-class, and the product roadmap is packed with catalysts.
Technical and valuation signals likewise suggest the stock may be entering a new bullish phase, with support levels proven, upward momentum building, and investor engagement high. UiPath’s unassailable position in automation and forward-looking product strategy make it a frontrunner among AI and software equities, particularly for those seeking diversified growth outside the crowded pure-play AI names.
With a target price of $16.80 (a 30% implied upside from current levels) and a confluence of favourable signals, UiPath seems to represent an excellent opportunity to consider for investors looking to access the future of automation software.
As the automation era accelerates, UiPath’s strong execution and strategic vision position the stock as a vehicle for long-term value creation and dynamic portfolio enhancement, making the present a potentially opportune moment for those seeking next-generation technology exposure.
How to buy UiPath stock in New Zealand?
Buying UiPath (PATH) stock online as a New Zealand retail investor is both straightforward and secure when using a regulated broker. You have two main options for gaining exposure: you can directly buy shares to become a shareholder ("spot buying"), or you can trade Contracts for Difference (CFDs) to speculate on price movements without owning the shares. Each approach has its own fees, risks, and advantages. To help you choose the right solution for your goals and budget, we provide a broker comparison further down this page.
Spot buying
When you buy UiPath stock “for cash” (spot buying), you are purchasing real shares, making you a part-owner of the company. In New Zealand, this is typically done through an NZX participant broker or an international online broker offering access to the NYSE. Typical fees include a fixed brokerage commission per order, often starting from around NZD $5 to $15 for US shares.
Example
For example, if UiPath's share price is USD $12.94 and the current NZD/USD rate is about 0.60, that's roughly NZD $21.57 per share. With a NZD $1,000 deposit, you can buy about 45 shares (after allowing for a typical NZD $5 brokerage fee).
Gain scenario:
If the share price rises by 10% (from USD $12.94 to $14.23), your shares are now worth NZD $1,100 (approx.), a gross gain of NZD $100, representing a 10% return on your investment.
Trading via CFD
CFD (Contract for Difference) trading allows you to speculate on the price movement of UiPath shares without actually owning them. With CFDs, you can profit from both rising and falling prices and use leverage (borrowing) to amplify your exposure. CFD fees typically include the spread (difference between buy and sell price) and, if you hold positions overnight, an overnight financing fee.
Example
For example, you open a CFD position on UiPath shares with NZD $1,000 and use 5x leverage. This gives you market exposure of NZD $5,000 (based on the underlying USD price converted to NZD).
Gain scenario:
If the stock rises by 8%, your position gains 8% × 5 = 40%. That’s a NZD $400 gain on your original NZD $1,000 (excluding any fees).
Final advice
Before investing, it’s important to compare brokers’ fees, platforms, and available features—costs and services can differ widely between providers. The best method ultimately depends on your investment objectives: choose spot buying if you want to hold real UiPath shares for the long term, or CFDs if you seek flexible, leveraged short-term trading. For a detailed comparison of leading brokers available to New Zealand investors, consult our broker comparison table further down this page.
Check out New Zealand's best brokers!Compare brokersOur 7 tips for buying UiPath stock
📊 Step | 📝 Specific tip for UiPath |
---|---|
Analyse the market | Research the growing demand for automation and AI in business, and assess how UiPath's leading position benefits from this global trend, particularly in NZ organisations seeking digital transformation. |
Choose the right trading platform | Select a reputable NZ-friendly broker that provides direct access to US markets (like the NYSE), ensuring you can trade PATH shares seamlessly with transparent foreign exchange processes. |
Define your investment budget | Decide on an amount you’re comfortable investing in US-listed tech shares, keeping in mind UiPath’s higher volatility and factoring in the NZD/USD exchange rate. |
Choose a strategy (short or long term) | Consider a long-term approach to benefit from UiPath’s strong ARR growth and innovations in agentic automation, in line with its positive financial outlook and market expansion. |
Monitor news and financial results | Stay updated on UiPath’s quarterly results, product launches, and global partnerships, as these events can move the share price and offer new insights for NZ investors. |
Use risk management tools | Utilise stop-loss and take-profit orders on your trading platform to manage risk, especially as UiPath tends to experience sharp price movements in response to earnings and sector news. |
Sell at the right time | Review your investment goals regularly and consider selling PATH shares when key milestones are met or before major US events that could increase volatility, such as earnings releases or executive changes. |
The latest news about UiPath
UiPath shares surged over 11% in after-hours trading on May 30, 2025, following robust Q1 results and raised guidance. This positive price action was driven by the company’s announcement of $357 million in revenue for the first quarter of FY2026, representing 6% year-over-year growth, along with a 12% increase in Annual Recurring Revenue (ARR) to $1.693 billion. The strong operating cash flow of $119 million and a non-GAAP adjusted free cash flow of $117 million reflect operational efficiency and ongoing business momentum. These results, combined with optimistic guidance for the next quarter and full fiscal year, reinforced positive sentiment among institutional investors and contributed to the stock's significant upward movement—an encouraging sign for New Zealand-based holders or prospective investors.
UiPath debuted its next-generation Agentic Automation Platform and introduced UiPath Maestro and Test Cloud, enhancing its AI capabilities and global competitiveness. Over the past week, the company launched a major update to its automation suite, unveiling the UiPath Platform™ for agentic automation, extending orchestration via Maestro for AI agents, and releasing Test Cloud—a fully cloud-native, AI-driven software testing solution. These new offerings are designed to support digital transformation needs across enterprises and will likely drive increased adoption in advanced tech markets such as New Zealand, where demand for RPA and AI workflows is accelerating, particularly among financial institutions and large corporates seeking scalability, efficiency, and compliance.
UiPath continued to expand strategic integrations, highlighted by bi-directional connectivity with Microsoft Copilot Studio announced this week. The partnership with Microsoft is of particular relevance to New Zealand's tech ecosystem, where Microsoft solutions—including 365 and Azure—are widely used by local businesses, government, and education sectors. Enhanced interoperability between UiPath and Microsoft Copilot Studio is poised to ease automation deployment for NZ enterprises, lower implementation barriers, and amplify productivity gains. This development strengthens UiPath’s competitive positioning in ANZ (Australia New Zealand) markets, supporting future ARR growth in the region.
UiPath’s leadership in global automation rankings was reaffirmed, earning top positions in the 2025 IDC MarketScape and Everest Group intelligence reports. Recognition as a leader for business automation platforms and intelligent document processing, announced within the last week, bolsters the company’s reputation with enterprise clients in highly regulated industries—a key constituency within New Zealand’s finance, insurance, and public sector verticals. Such recognition not only supports continued client acquisition globally, but also validates purchasing decisions by NZ organizations evaluating automation technology partners.
UiPath maintains a healthy financial position with $1.59 billion in cash, $77.8 million in total debt, and a current ratio of 2.93, mitigating risk in the current macro environment. This robust balance sheet gives the company ample capacity to fund innovation, pursue strategic partnerships (potentially including APAC-specific alliances), and weather economic volatility. For New Zealand investors and organizations with exposure to UiPath, this strength reduces counterparty risk and underpins confidence in the company’s sustainability as a long-term automation partner and global software leader.
FAQ
What is the latest dividend for UiPath stock?
UiPath does not currently pay a dividend. The company has a policy of reinvesting profits into growth and innovation rather than distributing cash to shareholders. This approach is typical for technology companies in expansion mode, especially those focusing on product development and market share in fast-evolving fields like automation and artificial intelligence.
What is the forecast for UiPath stock in 2025, 2026, and 2027?
Based on the current share price of $12.94, the projected end-of-year prices are $16.82 for 2025, $19.41 for 2026, and $25.88 for 2027. UiPath operates at the forefront of automation software and AI, benefiting from strong growth in Annual Recurring Revenue and new product launches. The company’s innovation and leadership in the RPA sector support a promising outlook.
Should I sell my UiPath shares?
Holding onto your UiPath shares could be a wise consideration given the company’s robust strategic positioning and financial health. UiPath combines high gross margins with significant investments in AI and automation, which are shaping future industry trends. Its ongoing product enhancements and leadership in automation platforms provide a solid foundation for long-term growth, making it appealing for investors who believe in the sector’s momentum.
How are capital gains and dividends from UiPath stock taxed for investors in New Zealand?
As a New Zealand investor, dividends from UiPath would be subject to U.S. withholding tax; however, UiPath does not currently pay dividends. Capital gains realised on UiPath shares are generally not taxed in New Zealand unless you are classified as a trader or dealing in shares regularly. It’s important to keep detailed records for your own tax purposes and to check if the Foreign Investment Fund (FIF) rules apply.
What is the latest dividend for UiPath stock?
UiPath does not currently pay a dividend. The company has a policy of reinvesting profits into growth and innovation rather than distributing cash to shareholders. This approach is typical for technology companies in expansion mode, especially those focusing on product development and market share in fast-evolving fields like automation and artificial intelligence.
What is the forecast for UiPath stock in 2025, 2026, and 2027?
Based on the current share price of $12.94, the projected end-of-year prices are $16.82 for 2025, $19.41 for 2026, and $25.88 for 2027. UiPath operates at the forefront of automation software and AI, benefiting from strong growth in Annual Recurring Revenue and new product launches. The company’s innovation and leadership in the RPA sector support a promising outlook.
Should I sell my UiPath shares?
Holding onto your UiPath shares could be a wise consideration given the company’s robust strategic positioning and financial health. UiPath combines high gross margins with significant investments in AI and automation, which are shaping future industry trends. Its ongoing product enhancements and leadership in automation platforms provide a solid foundation for long-term growth, making it appealing for investors who believe in the sector’s momentum.
How are capital gains and dividends from UiPath stock taxed for investors in New Zealand?
As a New Zealand investor, dividends from UiPath would be subject to U.S. withholding tax; however, UiPath does not currently pay dividends. Capital gains realised on UiPath shares are generally not taxed in New Zealand unless you are classified as a trader or dealing in shares regularly. It’s important to keep detailed records for your own tax purposes and to check if the Foreign Investment Fund (FIF) rules apply.